These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14587168)

  • 21. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction.
    Vetrano A; Carotenuto R; Corsini F; Schioppa M; Martone A; Melorio S; Sideri F; Romano S; Chieffo C; Corsini G
    Am J Cardiol; 2004 Apr; 93(7):914-6. PubMed ID: 15050497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facilitated PCI: rationale, current evidence, open questions, and future directions.
    Zimarino M; Sacchetta D; Renda G; De Caterina R
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):3-10. PubMed ID: 18209562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction.
    Martinez-Ojeda J; Martinez-Toro J
    Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary coronary intervention in acute myocardial infarction.
    Kim CX; Davidson CJ
    Ital Heart J; 2004 Jun; 5 Suppl 6():76S-82S. PubMed ID: 15185919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.
    Rao SV; O'Grady K; Pieper KS; Granger CB; Newby LK; Mahaffey KW; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Harrington RA
    J Am Coll Cardiol; 2006 Feb; 47(4):809-16. PubMed ID: 16487850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of successful reperfusion after thrombolysis.
    Henderson E
    Heart Lung; 1988 Nov; 17(6 Pt 2):761-71. PubMed ID: 3056888
    [No Abstract]   [Full Text] [Related]  

  • 29. Glycoprotein IIb/IIIa inhibitors and no-reflow.
    Kloner RA; Dai W
    J Am Coll Cardiol; 2004 Jan; 43(2):284-6. PubMed ID: 14736450
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proposed model of treatment of myocardial infarction with prolonged ST wave in Poland].
    PoloĊ„ski L; Gasior M; Wilczek K; Gierlotka M; Kalarus Z; Opolski G
    Kardiol Pol; 2006 Feb; 64(2):225-7. PubMed ID: 16502380
    [No Abstract]   [Full Text] [Related]  

  • 31. Reperfusion and antithrombotic strategies for acute MI.
    Belli G; Topol EJ
    Contemp Intern Med; 1995 Jul; 7(7):31-8, 43-5. PubMed ID: 10150611
    [No Abstract]   [Full Text] [Related]  

  • 32. GPIIb/IIIa inhibitor-induced dethrombosis.
    Furman MI; Frelinger AL; Michelson AD
    J Thromb Thrombolysis; 2004 Aug; 18(1):11-7. PubMed ID: 15744548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.
    Ray KK; Morrow DA; Gibson CM; Murphy S; Antman EM; Braunwald E
    Eur Heart J; 2005 Mar; 26(5):440-6. PubMed ID: 15673542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 35. Low-molecular-weight heparins for the treatment of acute coronary syndromes.
    Wong GC; Giugliano RP
    Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reperfusion strategies in acute ST-segment elevation myocardial infarction: acute angioplasty may be feasible for the majority of U.S. citizens.
    Terkelsen CJ; Nielsen TT
    J Am Coll Cardiol; 2008 Sep; 52(11):966-7; author reply 967-8. PubMed ID: 18772071
    [No Abstract]   [Full Text] [Related]  

  • 37. [DC shock and reperfusion in myocardial infarction with ST-segment elevation a hypothesis to be verified].
    Pezza B
    G Ital Cardiol (Rome); 2010 Mar; 11(3):261. PubMed ID: 20550069
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnosis and management of ST elevation myocardial infarction: a review of the recent literature and practice guidelines.
    Hahn SA; Chandler C
    Mt Sinai J Med; 2006 Jan; 73(1):469-81. PubMed ID: 16470326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of contemporary reperfusion strategies in acute ST-elevation myocardial infarction.
    Haude M; Schulz R; Heusch G; Erbel R
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):667-80. PubMed ID: 16076277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent trials of antithrombotics in the management of patients with acute coronary syndromes.
    Harrington RA
    Curr Cardiol Rep; 1999 Sep; 1(3):181-3. PubMed ID: 10980839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.